Rates of AKI with ACE Inhibitor and Angiotensin-Receptor Blocker Use

被引:0
|
作者
Tabet, Michael I. [1 ]
Sarrazin, Mary Vaughan [1 ]
Jalal, Diana I. [1 ]
Misurac, Jason [1 ]
Griffin, Benjamin R. [1 ]
机构
[1] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
来源
关键词
D O I
10.1681/ASN.2024yqy6y6x4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
FR-PO042
引用
收藏
页数:2
相关论文
共 50 条
  • [2] New angiotensin receptor blocker is as effective as ACE inhibitor
    Gottlieb, S
    BRITISH MEDICAL JOURNAL, 2003, 327 (7424): : 1123 - 1123
  • [5] COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy
    Kussmaul, William G., III
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (03) : 237 - 238
  • [6] Feasibility of treating prehypertension with an angiotensin-receptor blocker
    Julius, S
    Nesbitt, SD
    Egan, BM
    Weber, MA
    Michelson, EL
    Kaciroti, N
    Black, HR
    Grimm, RH
    Messerli, FH
    Oparil, S
    Schork, MA
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (16): : 1685 - 1697
  • [7] New angiotensin-receptor blocker approved by FDA
    Thompson, Cheryl A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (07) : 550 - 550
  • [8] Effects of an ACE inhibitor or angiotensin receptor blocker on potassium in CAPD patients
    Phakdeekitcharoen, B
    Leelasa-nguan, P
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (04) : 738 - 746
  • [9] Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation A Nationwide Cohort Study
    Hsieh, Yu-Cheng
    Hung, Chen-Ying
    Li, Cheng-Hung
    Liao, Ying-Chieh
    Huang, Jin-Long
    Lin, Ching-Heng
    Wu, Tsu-Juey
    MEDICINE, 2016, 95 (20)
  • [10] Renoprotection by angiotensin-receptor blockers and ACE inhibitors in hypertension
    Opie, LH
    LANCET, 2001, 358 (9296): : 1829 - 1831